Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 24699320)

1.

Ketamine helps a third of patients with treatment resistant depression, finds small UK study.

Torjesen I.

BMJ. 2014 Apr 3;348:g2576. doi: 10.1136/bmj.g2576. No abstract available.

PMID:
24699320
2.

Intravenous ketamine for treatment-resistant major depressive disorder.

Covvey JR, Crawford AN, Lowe DK.

Ann Pharmacother. 2012 Jan;46(1):117-23. doi: 10.1345/aph.1Q371. Epub 2011 Dec 20. Review.

PMID:
22190250
3.

Ketamine as an alternative treatment for treatment-resistant depression.

Dowben JS, Grant JS, Keltner NL.

Perspect Psychiatr Care. 2013 Jan;49(1):2-4. doi: 10.1111/ppc.12006. Epub 2012 Dec 30. Review. No abstract available.

PMID:
23293991
4.

Ketamine for the treatment of depression.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2013 Jan;51(1):11-4.

PMID:
23413455
5.

Repeated S-ketamine infusions in therapy resistant depression: a case series.

Segmiller F, Rüther T, Linhardt A, Padberg F, Berger M, Pogarell O, Möller HJ, Kohler C, Schüle C.

J Clin Pharmacol. 2013 Sep;53(9):996-8. doi: 10.1002/jcph.122. Epub 2013 Jul 24. No abstract available.

PMID:
23893490
6.

Ketamine for treatment-resistant depression: ready or not for clinical use?

Rush AJ.

Am J Psychiatry. 2013 Oct;170(10):1079-81. doi: 10.1176/appi.ajp.2013.13081034. No abstract available.

PMID:
23982324
7.

Ketamine as a novel antidepressant: from synapse to behavior.

Murrough JW.

Clin Pharmacol Ther. 2012 Feb;91(2):303-9. doi: 10.1038/clpt.2011.244. Epub 2011 Dec 28. Review.

8.

[Ketamine for treatment of acute depression].

Hjerrild S, Bjerre J, Pedersen RH, Videbech P.

Ugeskr Laeger. 2013 Sep 9;175(37):2090-3. Review. Danish.

PMID:
24011203
9.

A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression.

Szymkowicz SM, Finnegan N, Dale RM.

J Affect Disord. 2013 May;147(1-3):416-20. doi: 10.1016/j.jad.2012.10.015. Epub 2012 Nov 22.

10.

[Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression].

Gosek P, Chojnacka M, Bieńkowski P, Swiecicki Ł.

Psychiatr Pol. 2012 Mar-Apr;46(2):283-94. Review. Polish.

PMID:
23214398
11.

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV.

Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.

12.

A word to the wise about ketamine.

Schatzberg AF.

Am J Psychiatry. 2014 Mar;171(3):262-4. doi: 10.1176/appi.ajp.2014.13101434. No abstract available.

PMID:
24585328
13.

Ketamine for treatment-resistant unipolar depression: current evidence.

Mathew SJ, Shah A, Lapidus K, Clark C, Jarun N, Ostermeyer B, Murrough JW.

CNS Drugs. 2012 Mar 1;26(3):189-204. doi: 10.2165/11599770-000000000-00000. Review.

14.

Electroconvulsive therapy is a standard treatment; ketamine is not (yet).

Kellner CH, Greenberg RM, Ahle GM, Liebman LS.

Am J Psychiatry. 2014 Jul;171(7):796. doi: 10.1176/appi.ajp.2014.14030354. No abstract available.

PMID:
24980176
15.

[Ketamine's antidepressant effect: focus on ketamine mechanisms of action].

De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R.

Encephale. 2014 Feb;40(1):48-55. doi: 10.1016/j.encep.2013.09.002. Epub 2014 Jan 13. Review. French.

PMID:
24434007
16.

Reversal of non-suppression of cortisol levels in a patient with refractory depression receiving ketamine.

Ostroff R, Kothari JS.

Am J Psychiatry. 2015 Jan;172(1):95-6. doi: 10.1176/appi.ajp.2014.14060776. No abstract available.

PMID:
25553498
17.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
18.

Exploiting N-methyl-d-aspartate channel blockade for a rapid antidepressant response in major depressive disorder.

Blier P.

Biol Psychiatry. 2013 Aug 15;74(4):238-9. doi: 10.1016/j.biopsych.2013.05.029. No abstract available.

PMID:
23885752
19.

[Ketamine's antidepressant effect: literature review on clinical use].

De Maricourt P, Jay T, Goncalvès P, Lôo H, Gaillard R.

Encephale. 2014 Feb;40(1):15-23. doi: 10.1016/j.encep.2013.09.001. Epub 2014 Jan 14. Review. French.

PMID:
24434008
20.

Augmentation of response and remission to serial intravenous subanesthetic ketamine in treatment resistant depression.

Shiroma PR, Johns B, Kuskowski M, Wels J, Thuras P, Albott CS, Lim KO.

J Affect Disord. 2014 Feb;155:123-9. doi: 10.1016/j.jad.2013.10.036. Epub 2013 Oct 29.

PMID:
24268616
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk